Detalhe da pesquisa
1.
Targeting HER2 in Gastroesophageal Adenocarcinoma: Molecular Features and Updates in Clinical Practice.
Int J Mol Sci
; 25(7)2024 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38612688
2.
Circulating Tumor DNA in Gastric Adenocarcinoma: Future Clinical Applications and Perspectives.
Int J Mol Sci
; 24(11)2023 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37298371
3.
Preferred neoadjuvant therapy for gastric and gastroesophageal junction adenocarcinoma: a systematic review and network meta-analysis.
Gastric Cancer
; 25(5): 982-987, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35704113
4.
Anti-Claudin Treatments in Gastroesophageal Adenocarcinoma: Mainstream and Upcoming Strategies.
J Clin Med
; 12(8)2023 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37109309
5.
Krukenberg Tumor Related to Gallbladder Cancer in a Young Woman: A Case Report and Review of the Literature.
J Pers Med
; 13(6)2023 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37373946
6.
Osteonecrosis of the Jaw in a Breast Cancer Patient Treated with Everolimus and a Single Dose of Zoledronic Acid.
Breast J
; 23(5): 610-611, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28328105
7.
Multicentre match-paired analysis of advanced biliary cancer long-term survivors: The BILONG study.
Clin Res Hepatol Gastroenterol
; 46(8): 101955, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35609824
8.
Development and Multicenter Validation of a Novel Immune-Inflammation-Based Nomogram to Predict Survival in Western Resectable Gastric and Gastroesophageal Junction Adenocarcinoma (GEA): The NOMOGAST.
J Clin Med
; 11(18)2022 Sep 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36143086
9.
NTRK fusions in colorectal cancer: clinical meaning and future perspective.
Expert Opin Ther Targets
; 25(8): 677-683, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34488530
10.
Strategies for Increasing the Effectiveness of Aromatase Inhibitors in Locally Advanced Breast Cancer: An Evidence-Based Review on Current Options.
Cancer Manag Res
; 12: 675-686, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32099464
11.
Immune-related Adverse Events and Survival in Solid Tumors Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.
J Immunother
; 43(1): 1-7, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31574022
12.
Nivolumab-Induced Impressive Response of Refractory Pulmonary Sarcomatoid Carcinoma with Brain Metastasis.
Case Rep Oncol
; 11(3): 615-621, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30323751
13.
Necitumumab in the treatment of non-small-cell lung cancer: clinical controversies.
Expert Opin Biol Ther
; 18(9): 937-945, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30075697
14.
Resistance to EGFR inhibitors in non-small cell lung cancer: Clinical management and future perspectives.
Crit Rev Oncol Hematol
; 123: 149-161, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29482776
15.
Do immune checkpoint inhibitors need new studies methodology?
J Thorac Dis
; 10(Suppl 13): S1564-S1580, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29951307
16.
Putative predictors of efficacy for immune checkpoint inhibitors in non-small-cell lung cancer: facing the complexity of the immune system.
Expert Rev Mol Diagn
; 17(12): 1055-1069, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29032709
17.
Secondary biopsy of non-oncogenic-driven lung cancer may reveal a clinically sensible histologic change. A brief report of two paradigmatic cases.
Thorac Cancer
; 8(4): 359-362, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28383810